SCHEMBL19000707

SCHEMBL19000707

COc1cccc(Cn2ncc(Cl)c(Cl)c2=O)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 4/20 0.70
▸ NPSR1 Q6W5P4 4/20 0.70
▸ ALDH1A1 P00352 3/20 0.70
▸ LMNA P02545 3/20 0.70
▸ CYP1A2 P05177 1/20 0.70
▸ CYP3A4 P08684 1/20 0.70
▸ CYP2C19 P33261 1/20 0.70
▸ NPBWR1 P48145 11/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.59
▸ RAB9A P51151 3/20 0.58
▸ MAPT P10636 2/20 0.58
▸ RECQL P46063 1/20 0.58
▸ MITF O75030 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ AURKA O14965 1/20 0.53
▸ GRK2 P25098 1/20 0.53
▸ ROCK1 Q13464 1/20 0.53
▸ RPS6KA1 Q15418 1/20 0.53
▸ MCHR1 Q99705 1/20 0.53
▸ ROCK2 O75116 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2551062 0.85 NPBWR1 (0.77) HTTNPSR1ALDH1A1LMNACYP1A2
SCHEMBL12218257 0.83 HTT (1.00) HTTNPSR1ALDH1A1LMNACYP1A2
SCHEMBL9736936 0.81 HTT (0.64) HTTNPSR1ALDH1A1LMNACYP1A2
SCHEMBL1691901 0.80 HTT (0.71) HTTNPSR1ALDH1A1LMNACYP1A2
SCHEMBL19011793 0.80 HTT (0.71) HTTNPSR1ALDH1A1LMNACYP1A2
SCHEMBL19011761 0.80 HTT (0.71) HTTNPSR1ALDH1A1LMNACYP1A2
SCHEMBL19000709 0.79 ALDH1A1 (0.69) HTTNPSR1ALDH1A1LMNACYP1A2
SCHEMBL20435859 0.77 CYP1A2 (0.55) HTTNPSR1ALDH1A1LMNACYP1A2
SCHEMBL19000727 0.77 HTT (0.67) HTTNPSR1ALDH1A1LMNACYP1A2
SCHEMBL19011632 0.77 HTT (0.67) HTTNPSR1ALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS BAK1, DCLRE1B, BLVRB HTT 4458/4885NPSR1 4642/4885ALDH1A1 4273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback